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Abstract
Background: Enhanced recovery may be viewed as a comprehensive approach to improving meaningful
outcomes in patients undergoing major surgery. Evidence to support enhanced recovery pathways (ERPs) is
strong in patients undergoing colorectal surgery. There is some controversy about the adoption of specific
elements in enhanced recovery “bundles” because the relative importance of different components of ERPs
is hard to discern (a consequence of multiple simultaneous changes in clinical practice when ERPs are
initiated). There is evidence that specific approaches to fluid management are better than alternatives in
patients undergoing colorectal surgery; however, several specific questions remain.
Methods: In the “Perioperative Quality Initiative (POQI) Fluids” workgroup, we developed a framework broadly
applicable to the perioperative management of intravenous fluid therapy in patients undergoing elective
colorectal surgery within an ERP.
Discussion: We discussed aspects of ERPs that impact fluid management and made recommendations or
suggestions on topics such as bowel preparation; preoperative oral hydration; intraoperative fluid therapy with
and without devices for goal-directed fluid therapy; and type of fluid.
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1. We recommend unrestricted access to clear fluids
for oral intake up to 2 h before the induction of
anesthesia to maintain hydration while minimizing
the risk of aspiration.
2. We recommend that the clear fluid used to maintain
oral hydration contain at least 45 g of carbohydrate
to improve insulin sensitivity (except in type I
diabetics due to their insulin deficiency state).
We suggest that complex carbohydrate (e.g.,
maltodextrin) be used when available.
3. We recommend that clinicians avoid administration
of intravenous fluids to replace preoperative “fluid
losses” in patients who received iso-osmotic bowel
preparation provided there was unrestricted intake
of clear fluids for up to 2 h before the induction
of anesthesia. There is no evidence that iso-osmotic
mechanical bowel preparation leads to adverse
effects on preoperative volume status.
4. We recommend against the use of hyper-osmotic or
hypo-osmotic bowel preparations prior to surgery
since there is no benefit relative to iso-osmotic
bowel preparation and there may be adverse effects
on preoperative volume status.
During and after surgery
5. We recommend the application of a hemodynamic
framework to guide clinical decision-making during
surgery. We have developed such a framework and
suggest that the use of intraoperative goal-directed
fluid therapy (GDFT) is likely to be safe in the
majority of patients undergoing major colorectal
surgery. GDFT has little risk, and the use of
advanced hemodynamic monitoring equipment
may enhance clinical decision-making when
compared with the use of conventional monitors.
6. We suggest that the advanced hemodynamic
monitoring equipment used to guide clinical
decision-making intraoperatively be selected based
on a combination of surgical patient and institutional
factors since such monitoring can minimize both
hypovolemia (by promoting therapy in volume
responders) and hypervolemia (by restricting
therapy in non-responders).
7. We recommend that in isolation, intraoperative
oliguria should not trigger fluid therapy, as low
urine output is a normal physiologic response
during surgery and anesthesia. We also recommend
that intraoperative oliguria be investigated and that
absolute (as opposed to relative) hypovolemia be
ruled out.
8. We recommend that intraoperative and
postoperative anuria warrant immediate attention
since anuria is pathological.
9. We recommend that fluid management strategies
focus on the following: first, identifying if there is a
clinical problem that can be solved by fluid therapy
and then identifying what fluid and how much is
appropriate. Rather than treating every instance
of abnormal hemodynamic values (displayed by
conventional or advanced monitors), clinicians must
establish causation based on available information
about the patient and clinical context.
10.We recommend that therapy attempt to reverse the
most likely cause of a hemodynamic derangement.
Absolute hypovolemia may or may not be
responsible for observed hemodynamic
abnormalities. For instance, stroke volume
variation above 13% soon after the induction of
anesthesia and with the institution of mechanical
ventilation should prompt consideration of
vasodilation (relative hypovolemia) rather than
as the cause of fluid responsiveness. The patient
may hence require vasoconstrictors rather than
bolus fluid therapy provided clear fluids have
been consumed preoperatively and iso-osmotic
bowel preparation has been used.
11.We recommend the use of buffered isotonic
crystalloids for the treatment of hypovolemia in
patients undergoing colorectal surgical procedures.
We acknowledge that the restrictions on the use of
starch solutions are based on extrapolations from
the critical care literature.
12.We suggest that patients tolerating fluids orally after
surgery be given unrestricted access to such fluids as
this increases patient satisfaction and as it is likely
that intravenous fluid administration offer no added
benefit.
13.We suggest that the hemodynamic framework
utilized intraoperatively be extended into the
postoperative period to the extent possible, in
situations where patients might benefit from such
postoperative monitoring (high-risk patients or
those with significant blood loss or complications
during surgery).
Background
Outcomes such as complication rates, readmissions, and
length of stay may be highly variable across different
centers conducting colorectal surgery (Cohen et al.
2009). Enhanced recovery pathways (ERPs), initially led
in Europe (by the surgeon Henrik Kehlet), were devel-
oped in the 1990s in an effort to reduce such variability
(Kehlet 1997). ERPs generally share certain core features
but also have subtle differences across and even within
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sites (reflecting unique institutional needs, capabilities,
and resource availability). Most ERPs focus on setting pa-
tient expectations and involving the patient in their own
care pathway for fast recovery, avoiding prolonged pre-
operative restriction of fluid intake, avoidance of empirical
intravenous fluid loading, minimization of systemic opioid
use, and early postoperative ambulation. In several studies
examining effects of ERP implementation (versus data
prior to implementation), an average reduction in length
of stay of 3 days appeared to result in over 3000 subjects
across several institutions and in a variety of surgical pro-
cedures (Thiele et al. 2015a). Meta-analyses on ERPs in
colorectal surgical procedures found similar reductions in
length of stay (~2.5 days) without an increase in readmis-
sion rates (Zhuang et al. 2013; Varadhan et al. 2010).
Retrospective and prospective studies of ERPs in colo-
rectal surgery have typically examined “bundled” inter-
ventions making it difficult to estimate the relative value
of specific elements related to perioperative fluid man-
agement. Outside the context of an ERP, investigators
have defined outcomes following “liberal” and “restrict-
ive” fluid strategies during colorectal surgery. However,
there is no shared definition of what amount constitutes
either (Chappell et al. 2008). Calculations of intraopera-
tive fluid deficits during colorectal surgery have, prior to
ERP, included so-called “third space” losses and peri-
operative fluid therapy was guided by static indicators of
volume status. A recent comprehensive review summa-
rized this as follows: “Research suffers from a lack of
standardization…Investigators have normally named
their traditional regimen the standard group and com-
pared it with their own restrictive ideas… A restrictive
regimen in one study is often designated as liberal in an-
other setup…This shortcoming prevents even promising
results from impacting daily clinical routine and makes
any pooling of the data impossible.” (Chappell et al.
2008) Thus, several specific questions, related to fluid
therapy, remain. The “fluids” subgroup within the first
Perioperative Quality Initiative (POQI) sought to define
and answer important questions related to perioperative
fluid management in patients undergoing colorectal sur-
gery within the context of an ERP.
Methods/design
Applying a modified Delphi method, designed to use the
collective expertise of a diverse group of experts to an-
swer clinical questions, we achieved consensus on sev-
eral topics related to perioperative fluid management in
patients undergoing colorectal surgery within the con-
text of an ERP.
Expert group
An international group of authorities, with specific con-
tent area expertise (based on the conduct of research
and education in this area), was invited to participate. In
total, 32 experts from around North America and
Europe met in Durham, NC, on March 4–5, 2016, to
iteratively discuss the evidence supporting enhanced re-
covery paradigms and develop consensus statements
with practical recommendations for clinicians.
Process
A list of relevant questions was collectively developed
and circulated electronically prior to the meeting. Based
on literature searches performed by members, questions
were formulated. In the first plenary session, the POQI
perioperative fluid management subgroup presented
these questions to the entire POQI workgroup, to
receive feedback and assistance in refining the questions.
The subgroup then worked together to formulate an-
swers to these questions, supported by evidence when
available and by expert opinion when no clear evidence
was available. These were presented in the second plen-
ary session. After receiving feedback, the subgroup re-
fined a series of consensus statements, which was then
reviewed with and modified by the entire POQI group in
the final plenary session. This manuscript is based on
these multiple rounds of feedback from all the experts
present at the first POQI meeting.
Results
Based on both discussions (held prior to the conference)
and the literature (identified by the participants), the fol-
lowing questions were considered most relevant to peri-
operative fluid management before, during, and after
colorectal surgery within an ERP:
Prior to surgery
(i) What are the effects of preoperative oral intake of
clear solutions (containing complex versus simple
carbohydrates) up to 2 h prior to the induction of
anesthesia?
(ii)Does mechanical bowel preparation contribute to
preoperative hypovolemia?
During and after surgery
(iii) Is urine output a valid indicator of perioperative
fluid needs?
(iv) Is there a rational approach to intraoperative fluid
management based on the current evidence?
(v) Which types of fluids should be used
intraoperatively?
(vi) How do variations in surgical and anesthesia
technique affect intraoperative fluid management?
(vii)How should fluid therapy be managed
postoperatively?
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(i) What are the effects of preoperative oral intake of
clear solutions (containing complex versus simple
carbohydrates) up to 2 h prior to the induction of
anesthesia?
It has known that both simple (e.g., glucose) and com-
plex (e.g., maltodextrin) carbohydrate-containing solu-
tions prevent protein catabolism following exercise
(Borsheim et al. 2004; Roy et al. 1997). Whether this is
true in the perioperative period has not, until recently,
been known. In animals, oral maltodextrin solution prior
to sham surgery reduces protein catabolism versus fast-
ing (with ad libitum water) (Luttikhold et al. 2013). A
trial comparing a high to low maltodextrin beverages be-
fore surgery found stable post-surgical protein balance
in the high but negative whole-body protein balance in
the low group (Svanfeldt et al. 2007). Such data suggest
that preoperative oral intake of clear solutions containing
certain carbohydrates may prevent perioperative protein
catabolism. Larger studies are needed to better examine
impact on meaningful clinical outcomes such as length of
stay or surgical complications. In a recent Cochrane Re-
view including 1976 participants in 27 trials comparing
preoperative carbohydrate loading with placebo, where
preoperative carbohydrate loading was defined as the in-
take of at least 45 g of carbohydrates within 4 h prior to
surgery, a trend towards improved postoperative insulin
resistance was demonstrated (as measured by the Homeo-
static Model Assessment of Insulin Resistance (HOMA-
IR)) (Smith et al. 2014). On the other hand, a different
meta-analysis showed that although there was a tendency
toward reduction of postoperative insulin resistance, pre-
operative carbohydrate loading made no difference to the
rates of postoperative complications (Awad et al. 2013).
In non-diabetic colectomy patients, it appears that up-
wards of 25% are at risk for postoperative hyperglycemia
with associated risks of SSI and mortality, presumably
from acute insulin resistance (Kwon et al. 2013). Measur-
ing insulin sensitivity with the hyperinsulinemic euglyce-
mic clamp method, carbohydrate loading (as compared
with placebo or fasting) demonstrated a trend towards
increased postoperative insulin sensitivity (sensitivity
difference 0.24 to 1.29, p = 0.0046) (Smith et al. 2014).
Additionally, Cochrane analysis identified a reduction in
length of stay of 0.30 days with carbohydrate loading
versus fasting but not versus placebo (−0.12 days, 95%
confidence interval −0.38 to 0.12 days) (Smith et al. 2014).
Much (but not all) of the data on preoperative carbohy-
drate loading was based on the use of maltodextrin-
containing solutions. Direct comparisons with more
readily available simple sugar containing solutions (e.g.,
glucose) have not been made. However, there are signifi-
cant data suggesting the negative impact of a high versus
low glycemic index meal on the response of glucose, insu-
lin, and glucagon (Harbis et al. 2004).
Overall, based on the low risk of harm, potentially im-
proved nitrogen balance, and better insulin sensitivity
following colorectal surgery, we recommend the oral
intake of carbohydrate-containing solutions prior to sur-
gery and suggest that solutions containing complex car-
bohydrates be used when available. We acknowledge
that cost and convenience may be barriers to the use of
such solutions. It is worth noting that in patients with
type I diabetes, provision of such solutions may offer no
benefit over electrolyte-containing water with the pos-
sible exception of improved nitrogen balance. Lastly, in
order to minimize potential risks of aspiration, as de-
tailed in the guidelines issued by the American Society
of Anesthesiologists (ASA), the oral intake of clear liq-
uids should occur more than 2 h prior to the induction
of anesthesia. ASA guidelines recommend modification
of preoperative fasting on an individual basis in the pres-
ence of “gastroesophageal reflux disease, dysphagia
symptoms, or other gastrointestinal motility disorders.”
(American Society of Anesthesiologists C 2011)
(ii) Does mechanical bowel preparation contribute to
preoperative hypovolemia?
The traditional view, that mechanical bowel preparation
(MBP) may lead to hypovolemia due to gastrointestinal
losses prior to colorectal surgery, was supported by a
study comparing ten subjects randomized to Picolax
(magnesium citrate (a hyper-osmotic laxative) and so-
dium picosulfate (a stimulant)) versus not. There was
significantly more orthostasis and tachycardia in the
group that received the hyper-osmotic bowel preparation
(Barker et al. 1992). In a subsequent trial comparing 41
patients receiving Picolax randomized to oral intake and
protocoled intravenous fluid administration versus oral
intake alone, there was more weight loss, hemoconcen-
tration, and orthostasis (a highly specific, but relatively
insensitive marker for hypovolemia and fluid responsive-
ness) in the group receiving no intravenous fluid
(Sanders et al. 2001). Similar investigations on hyper-
osmotic MBP with bisacodyl, sodium phosphate, and
metoclopramide, followed by prespecified fluid intake
over 3 days (in 12 healthy volunteers) revealed a median
weight loss of 1.2 kg, decrease in exercise tolerance (me-
dian 9% reduction in watts), but no changes in orthosta-
sis (Holte et al. 2004). The small sizes of these studies,
relative health of the volunteers, and the lack of surgery
make it challenging to interpret these data, although
weight loss (presumably due to fluid losses from the
gastrointestinal tract) is incontrovertible.
In a clinical study of 19 patients undergoing laparo-
scopic colonic surgery after MBP (bisacodyl, polyethyl-
ene glycol 24 h preoperatively), the mean cardiac index
was 2.66 L/m2 (normal range 3.5–5) based on transpul-
monary thermodilution, after induction of anesthesia.
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The authors concluded that hypovolemia was likely to
be present (Junghans et al. 2006). Unfortunately, the lack
of control comparators makes attribution of changes in
cardiac index to MBP difficult. The effects of induction
of general anesthesia cannot be controlled for. In a
meta-analysis of prospective trials studying MBP for
colorectal surgery examining the risk of “cardiac events,”
MBP was associated with an increased incidence of such
events (2.9 versus 4.6% among 2472 patients included
in the meta-analysis) (Gravante et al. 2008).
Modern MBP techniques typically utilize iso-osmotic
agents, which in theory do not produce dehydration (no
osmotic shift in fluids toward the bowel lumen). When
combined with the emphasis on intake of clear fluids up
to 2 h before surgery (see question i) in compliance with
the ASA Fasting Guidelines, concerns related to the im-
pact of MBP on volume status are minimal. There is no
need for fluid therapy to treat presumed fluid losses
from iso-osmotic MBP and starvation. The shift in prac-
tice away from empiric administration of fluid therapy
toward therapy based on the detection of “fluid respon-
siveness” (defined as a specified increase in cardiac out-
put following fluid administration, typically at least by
10%) has further diminished arbitrary preoperative
intravenous hydration. If clinicians are able to rapidly
identify hypovolemia intraoperatively, excessive pre-
operative fluid losses can be detected and managed
objectively. Since it has not been established that iso-
osmotic MBP predisposes patients to hypovolemia, and
since clinicians can identify patients in whom MBP
might have produced excessive fluid losses promptly
(utilizing methods such as respiratory variation in the
plethysmography preoperatively (Tsuchiya et al. 2010),
we recommend against empiric pre-emptive intravenous
fluid therapy to correct MBP-induced hypovolemia. In
summary, while some data have previously suggested
that hyper-osmotic MBP leads to dehydration before
surgery (with increased risk of perioperative adverse car-
diac events), there is no evidence that iso-osmotic MBP
leads to any hemodynamic perturbations or increased
cardiac risk among patients allowed unrestricted access
to clear fluids for oral intake prior to surgery.
(iii) Is urine output a valid indicator of perioperative fluid
needs?
Traditionally, urine output has been viewed as an indica-
tor of the adequacy of kidney perfusion. Anuria is abnor-
mal and should always be a cause for concern
warranting prompt investigation. However, oliguria, de-
fined as urine output less than 0.5 mL/kg/h by the Kid-
ney Disease: Improving Global Outcomes (KDIGO)
group, is more challenging to interpret as abnormal, es-
pecially when other indicators of overall tissue perfusion
are normal (Section 2: AKI Definition. Kidney Int Suppl
2012).
For instance, it is now understood that the release of
vasopressin (antidiuretic hormone) is a natural response
to anesthesia and surgery. The resorptive actions of
vasopressin on the collecting duct in nephrons lead to
the retention of water with accompanying oliguria—this
may not indicate organ dysfunction (Cochrane et al.
1981). In 1984, a study from the Cleveland Clinic cast
doubt on the utility of perioperative oliguria as an indi-
cator of tissue hypoperfusion requiring fluid therapy.
Among 137 patients undergoing aortic reconstruction
surgery, mean intraoperative urine output or lowest in-
traoperative urine output had no relationship to changes
in postoperative BUN or creatinine levels (Alpert et al.
1984). More recently, in a meta-analysis (of 1594
patients across 15 studies) examining whether intraoper-
ative fluid restriction leads to perioperative acute kidney
injury (AKI), there was a trend towards oliguria (OR
2.07, 95% CI 0.97 to 4.44) but there was no difference in
the incidence of AKI (OR 1.07, 95% CI 0.60 to 1.92)
(Egal et al. 2016a). Further support for the insensitivity
of oliguria is provided by analysis of 1444 cases where
the administration of less than or equal to 3 mL/kg/h of
crystalloid during surgery was not associated with the
development of AKI (Ahn et al. 2016). This study also
found no difference in rates of oliguria and intraopera-
tive urine output among patients that developed AKI
versus those that did not (Ahn et al. 2016).
In contrast, there are data suggesting that high vol-
umes of postoperative urine may indicate recovery and
predict early readiness for discharge among patients
undergoing colorectal surgery (Johnson et al. 2015). In
order to study the effect of forced diuresis, Egal et al. an-
alyzed the impact of oliguria reversal (i.e., targeting a
specific urine output) on outcomes in a heterogenous
population of 4825 patients in 28 studies undergoing
GDFT. They found that while GDFT algorithms with a
specific urine target did not reduce AKI compared to
conventional fluid management (CFM) but that GDFT
algorithms that ignored urine output did (Egal et al.
2016b). Additionally, there is some evidence in cardiac
surgical patients that the administration of furosemide
(presumably to reverse oliguria) leads to increased serum
creatinine (Lassnigg et al. 2000). Such data suggest that
while anuria is abnormal, oliguria is a normal “stress” re-
sponse to surgery even conferring some clinical benefit.
There are also data suggesting that the reversal of
oliguria either attenuates the potential benefits of proto-
colized hemodynamic management strategies or even
causes harm (Egal et al. 2016b). While much of this
data—on urine output and renal function—comes from
patients undergoing non-colorectal procedures (and in
some cases, non-surgical patients), there are no
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prospective, randomized controlled trials comparing
oliguria reversal (forced diuresis) to more conventional
management in patients undergoing colorectal surgery.
There is no evidence that urine output is a valid indica-
tor of a need for fluid therapy in patients undergoing
colorectal surgery. We recommend that low urine out-
put, as an isolated abnormality, should not trigger fluid
therapy and should trigger diagnostic efforts.
(iv) Is there a rational approach to intraoperative fluid
management based on the current evidence?
Minimally invasive devices, that reflect cardiac output in
real time without pulmonary artery catheterization, have
allowed the perioperative measurement of global blood
flow. Fluid therapy guided by such devices may thus be
based on “fluid responsiveness” where repeated adminis-
tration of fluid boluses occurs when patients “respond”
to fluids (by objectively increasing global blood flow).
Minimally invasive cardiac output monitoring-guided
fluid management has been studied in multiple random-
ized controlled trials in patients undergoing diverse pro-
cedures (Sinclair et al. 1997; Gan et al. 2002; Venn et al.
2002; Wakeling et al. 2005; Noblett et al. 2006; Chytra et
al. 2007; Pillai et al. 2011; Jones et al. 2013; Ni et al.
2013), including abdominal surgery. The sum of these
studies suggest that application of minimally invasive
cardiac output monitoring can reduce the length of stay
(Sinclair et al. 1997; Gan et al. 2002; Venn et al. 2002;
Wakeling et al. 2005; Noblett et al. 2006; Chytra et al.
2007; Pillai et al. 2011; Jones et al. 2013; Ni et al. 2013).
Brandstrup et al. offered an alternative to perioperative
minimally invasive cardiac output monitoring, by dem-
onstrating that a “zero-fluid balance” approach was as
effective in terms of length of stay as well as incident
complications (Brandstrup et al. 2003). How could it be
that the initial GDFT studies, as conducted by Gan et al.,
suggested significant benefit with minimally invasive car-
diac output monitoring (reduced length of stay), but that
more recent studies show that similar benefits can be ac-
crued by paying meticulous attention to avoiding fluid
overload and maintaining “zero balance” (without the
use of additional devices) (Gan et al. 2002; Brandstrup et
al. 2003)? These apparently “conflicting” results may be
reconciled by understanding that clinical trials examine
outcomes relative to a comparator group. Depending on
the fluid management strategies in this control group,
achieving near-maximal stroke volume with a GDFT ap-
proach either offers an advantage (when the alternative
is empirically “liberal” therapy) or is equivalent (when
the alternative is “restrictive”) (Chappell et al. 2008).
Thus, a rational interpretation of evidence is that
there is potential benefit from GDFT using minim-
ally invasive cardiac output monitoring devices by
both avoiding unnecessary fluid therapy in volume
non-responders and avoiding inadequate fluid therapy
and hypoperfusion in volume responders (Bellamy’s
conceptual model for keeping patients “optimized”)
(Bellamy 2006).
There is little evidence that GDFT poses significant
risk. The concern regarding widespread implementation
is cost(s). Several investigators have examined device-
guided GDFT in the modern era of ERPs. Three such
groups independently tested a “zero balance” or “re-
strictive” strategy against conventional minimally inva-
sive cardiac output monitoring -guided GDFT within
the context of colorectal ERPs, and all found no differ-
ence in the length of stay or incident complications (335
total subjects studied) (Brandstrup et al. 2012; Srinivasa
et al. 2013; Phan et al. 2014). None of these studies
showed harm from GDFT. Analyzing the economic im-
pact of esophageal Doppler-based GDFT in major ab-
dominal surgery, but the National Institute for Health
and Care Excellence (NICE) Group said that there is
“cost saving per patient … when compared with the use
of a central venous catheter in the perioperative period”
(Excellence NIfHaC 2011). Since minimally invasive car-
diac output monitoring devices are not universally used
in the perioperative period, we developed a generalizable
framework for perioperative fluid management incorpor-
ating such devices (Fig. 1) (Cannesson et al. 2011). Our
framework does not suggest use of an algorithmic proto-
col (based on measures of cardiac output or surrogates)
for all patients undergoing colorectal surgery; rather, we
suggest that device-derived measures be placed in clin-
ical context. For instance, fluid responsiveness rather
than prompting a fluid bolus at all times may only
prompt a fluid bolus when coupled with evidence of ab-
solute hypovolemia. Abnormal physiologic values may
be warning signs (not endpoints for fluid therapy), and
clinical decision-making can be supplemented not re-
placed by the use of advanced hemodynamic monitoring
devices (details are beyond the scope of this review but
are discussed elsewhere) (Thiele et al. 2015b). Since in-
traoperative GDFT data suggests either a reduction in
length of stay and complications or equipoise (albeit at
higher overall cost) and also because most devices used
for GDFT present minimal risk to the patient, we rec-
ommend the use of GDFT when available. We acknow-
ledge that within ERPs for colorectal surgery, a “zero
balance” approach appears to be an acceptable alterna-
tive; we do not recommend a simple “recipe book” fluid
restriction (e.g., X ml/kg/hr) (Brandstrup et al. 2012;
Srinivasa et al. 2013; Phan et al. 2014). This statement is
supported by meta-analysis on GDFT within ER proto-
cols (Rollins and Lobo 2016). The most benefit from
GDFT is likely in certain subsets of patients rather than
all patients undergoing colorectal surgery with ERPs.
Depending on patient- and procedure-specific risks,
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clinicians may utilize conventional monitors or minim-
ally invasive cardiac output monitoring devices (Fig. 2).
Frameworks for three different risk categories are pre-
sented in Fig. 3.
(v) Which fluids should be used intraoperatively?
Most intraoperative GDFT studies used colloids as the
fluid of choice for volume expansion. However, colloids
were also administered in the control arms of such trials
Fig. 1 Suggested clinical framework for managing perioperative hemodynamics in patients undergoing colorectal surgical procedures
Thiele et al. Perioperative Medicine  (2016) 5:24 Page 7 of 15
thereby making it impossible to tease out the impact of
colloid solutions alone (Egal et al. 2016a). It is reason-
able to conclude that if colloids are going to be used,
then a GDFT approach offers benefits. On the other
hand, it is unclear that colloids are necessary. In a trial
randomizing patients undergoing laparoscopic segmental
colectomy within the context of an established ERP to
three groups (with all groups receiving lactated Ringer’s
at 5 mL/kg/h during the surgical procedure and
anesthesia): standard fluid therapy (22 patients) versus
intraoperative GDFT with lactated Ringer’s (21 patients)
versus intraoperative GDFT with hetastarch (21 pa-
tients), the length of stay was longer in the GDFT
groups. Furthermore, the group randomized to GDFT
with lactated Ringer’s solution received the highest
amount of intraoperative fluids while the group
randomized to GDFT with hetastarch received the high-
est amount of fluids during hospitalization (Senagore et
al. 2009). Yates et al. randomized 202 medium to high-
risk patients undergoing colorectal surgery to receipt of
a background infusion of crystalloid during the surgical
procedure (1.5 mL/kg/h of Hartmann’s solution) and
hemodynamic optimization (GDFT) with either Hart-
mann’s solution (chloride-restrictive crystalloid solution)
or 6% HES (130/0.4, Volulyte, suspended in similar so-
lution). The results showed that there was no difference
in complication rates, although the crystalloid group re-
ceived more fluid than the colloid group (Yates et al.
2014). Unfortunately, there are no large, multicenter,
prospective randomized controlled trials comparing
crystalloid to colloid solutions intraoperatively in a
GDFT protocol. Thus, when making determinations
Fig. 2 Suggested, risk-based algorithm for implementation of perioperative goal-directed in patients undergoing colorectal surgical procedures in
the context of an enhanced recovery protocol
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about which fluid types are most appropriate intraopera-
tively, clinicians are faced with either applying the results
of these two small, single center trials, or extrapolating
data from large crystalloid-colloid trials in unrelated
populations (e.g., sepsis).
Two such trials—comparing human-derived colloids
(albumin) to crystalloid in critically ill patients—found no
difference in the primary outcome of 28-day mortality
(Finfer et al. 2004; Caironi et al. 2014). Three trials—com-
paring synthetic colloids (hydroxyethyl starch solutions)
to crystalloids in critically ill patients—found either an
increased risk of death or an increased use of renal
replacement therapy (Brunkhorst et al. 2008; Perner et al.
2012; Myburgh et al. 2012). However, synthetic colloids
appeared beneficial (in terms of better survival) in an
open-label trial of critically ill hypovolemic patients
(Annane et al. 2013). A meta-analysis (59 randomized
controlled trials with a total of 16,889 subjects) comparing
crystalloids with colloids in a variety of patient populations
concluded that synthetic colloids were associated with a
risk of AKI and need for renal replacement therapy. Of
note, subgroup analysis showed that risks were largely in
patients with sepsis. General restrictions on the periopera-
tive use of colloids are not supported by this evidence, but
no sustained clinical benefits were evident with colloid use
(Qureshi et al. 2016).
We therefore recommend the use of crystalloids for
the treatment of hypovolemia in patients undergoing
colorectal surgical procedures. We acknowledge that al-
bumin may be safe but is more costly. We suggest that
isotonic chloride-restrictive crystalloids be used based
on a large body of retrospective data (Raghunathan et al.
2015; Shaw et al. 2015; Shaw et al. 2012) and some pro-
spective trials (Shaw et al. 2015; Shaw et al. 2012). The
biologic basis for such use (of chloride-restrictive buff-
ered crystalloids over chloride-liberal solutions such as
isotonic saline) is related to increased risk of hyper-
chloremic acidosis with the adverse pathophysiological
and clinical outcomes when saline is used (Disma et al.
2014; Potura et al. 2015; Chowdhury et al. 2012;
McCluskey et al. 2013; Krajewski et al. 2015; Lobo
and Awad 2014). A detailed discussion of blood prod-
ucts is beyond the scope of this manuscript. However,
we note that red blood cells have the potential for
harm and blood loss should be replaced with blood
products only when the risks are justified by signifi-
cant anemia (Hebert et al. 1999; Hajjar et al. 2010;
Carson et al. 2011).
(vi) How do variations in surgical and anesthesia
technique affect intraoperative fluid management?
The administration of fluid therapy intraoperatively
depends on demonstrable “fluid responsiveness” (i.e., ob-
jective evidence that fluid therapy augments circulation).
Several surgical maneuvers (e.g., Trendelenberg position-
ing, insufflation of the peritoneum for laparoscopy) as
well as by anesthetic interventions (low tidal volume
ventilation, use of positive end expiratory pressure
(PEEP), utilization of thoracic epidural analgesia with
local anesthetics) may impact measures of “fluid
responsiveness.” Understanding the physiologic impli-
cations of these maneuvers can help clinicians
contextualize changes in device-based measures and
avoid the use of fluid therapy based only on the pres-
ence of “fluid responsiveness” without attendant abso-
lute hypovolemia.
Trendelenberg positioning
While Trendelenberg (“head down”) positioning has
been used for over a century in an effort to improve
hemodynamics by augmenting venous return, its intra-
operative use is primarily for better visualization of the
operative site. Immediately after placing a patient in the
head down position, there is a transient increase in right
ventricular preload and stroke volume from increased
venous blood flow (from the lower extremities and
unstressed compartments). This subsequently leads to
increased left ventricular output and cardiac output
measurements taken 3–5 min after initiating the head
down position show an increase in cardiac index
(Sibbald et al. 1979). However, these changes are transient,
as there is re-equilibration over time (Magder et al. 2009)
and global flow returns to baseline within 10–15 min
(Ostrow et al. 1994). Thus, we recommend that clinicians
Fig. 3 Proposed risk stratification scheme for patients undergoing
colorectal surgical procedures in the context of an enhanced
recovery protocol
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avoid assuming that head down positioning has a sus-
tained benefit (long-term increase in preload) with durable
improvement in intraoperative hemodynamics.
Laparoscopy
Peritoneal insufflation is particularly relevant in patients
undergoing colorectal surgery within ERPs, since minim-
ally invasive surgical techniques are a cornerstone of
enhancing recovery. As with positioning, hemodynamic
changes with the initiation of laparoscopy are transient.
For instance, 5 min after initiation of a 14 mmHg pneu-
moperitoneum, cardiac index is significantly less than
immediately prior to abdominal insufflation. However,
10 min later, there is a return to baseline (Joris et al.
1993). A recent analysis of laparoscopy to an intrabdom-
inal pressure of 14 mmHg confirmed these findings
(Alfonsi et al. 2006). It is important for clinicians to note
that there is a sustained increase in mean arterial pres-
sure with insufflation. Hence, while the shifts in blood
volume (between stressed and unstressed compart-
ments) are transient, the increased afterload (hyperten-
sion) is sustained (Joris et al. 1993; Alfonsi et al. 2006;
Liu et al. 2015).
Insufflation increases the absolute value of measures
such as stroke volume variation and plethysmography
(Liu et al. 2015), meeting the threshold defining of “fluid
responsiveness.” This does not imply that fluid therapy
is needed (as discussed in question iv above) (Guinot et
al. 2014). Clinicians should anticipate increases in blood
pressure with minimal overall sustained changes in car-
diac output (with insufflation to 14 mmHg or less). We
suggest that measures of fluid responsiveness (based on
cardiorespiratory interactions) are less specific after ab-
dominal insufflation. This increase in “false positives”
needs to be accounted—contextualized—as suggested in
the framework we have described.
Low tidal volume
Lower tidal volumes confer a mortality benefit to critic-
ally ill patients with acute respiratory distress syndrome
(ARDS) (Ventilation with lower tidal volumes as com-
pared with traditional tidal volumes for acute lung injury
and the acute respiratory distress syndrome. The Acute
Respiratory Distress Syndrome Network. N Engl J Med
2000). The concept of “lung protective ventilation” has
expanded into the operating room environment and may
improve outcomes in patients (Lellouche et al. 2012;
Futier et al. 2013; Severgnini et al. 2013). As cardiorespi-
ratory interactions depend on cyclic changes in intratho-
racic pressure producing corresponding cyclic changes
in venous return, thresholds for “fluid responsiveness”
that utilize respiratory variation in pulse pressure or
systolic pressure are conditional on tidal volumes of
8–12 mL/kg (predicted body weight (PBW))
(Tavernier et al. 1998; Kramer et al. 2004). Lower
tidal volumes thus increase “false negatives” decreas-
ing arterial respiratory variation based measures of
“fluid responsiveness” (Lansdorp et al. 2012; De
Backer et al. 2005; Suehiro & Okutani 2011; Reuter et
al. 2003). Of note, clinical trials which use respiratory vari-
ation to guide fluid management utilize tidal volumes on
average of 7.8 mL/kg (range 6–9.1 mL/kg) (Benes et al.
2010; Forget et al. 2010; Ramsingh et al. 2013; Goepfert et
al. 2013). We recommend that clinicians utilizing arterial
(or plethysmographic) respiratory variation as a guide to
“fluid responsiveness” expect a reduction in sensitivity
with low tidal volume ventilation. Approaches that do not
rely on such respiratory variation, such as measured re-
sponse to a fluid bolus (e.g., mini-fluid challenge (Wu et
al. 2014; Muller et al. 2011)), are not affected.
High positive end expiratory pressure
Intraoperative mechanical ventilation may now incorp-
orate PEEP (e.g., 6–8 cm H2O utilized by Futier et al.)
(Futier et al. 2013). Such PEEP has a hemodynamic im-
pact as a result of increase in intrathoracic pressure
(with impedance of venous return) and a decrease in left
ventricular afterload (increasing the cardiac index). The
overall effect is a balance between these. In general, it
appears that PEEP above 5–10 cm H2O, leads to a
decrease in cardiac index (Van Trigt et al. 1982; Terai et
al. 1985; Huemer et al. 1994). Both animal and human
data suggest that such decreases in cardiac index accom-
panying higher levels of PEEP can be reversed with fluid
administration (Canfran et al. 2013; van den Berg et al.
2002; Renner et al. 2008). Furthermore, it appears that
higher levels of PEEP increase dynamic indicators of
fluid responsiveness (such as stroke volume variation)
reducing the utility of these metrics as predictors of fluid
responsiveness. We suggest that clinicians anticipate that
PEEP greater than 5 cm H2O may decrease cardiac
index, lower systemic blood pressure, and reduce the
specificity of arterial (or plethysmographic) respiratory
variation as guides to “fluid responsiveness.”
Thoracic epidural placement
The use of regional or neuraxial anesthesia is a major
component of many ERPs, with thoracic epidural anal-
gesia (TEA) most commonly used for open abdominal
surgical procedures. TEA with local anesthetics can
leads to hypotension from reduction in venous return
(sympathectomy with venodilation) and decreases in car-
diac index (Gelman et al. 1980). Arterial vasodilation
also occurs (which lower systemic vascular resistance)
(Goertz et al. 1992; Baron et al. 1986). Lower doses of
local anesthesia have been shown to preserve cardiac
index in patients receiving a TEA (Tanaka et al. 1991;
Hasenbos et al. 1988). These changes induced by TEA
Thiele et al. Perioperative Medicine  (2016) 5:24 Page 10 of 15
are best thought of as shifts in internal blood volu-
me—relative hypovolemia. Thus, low dose infusions of
catecholamines will counteract these effects preserv-
ing cardiac index, and fluid therapy is not necessary
(Gelman et al. 1980). We suggest that clinicians elect-
ing to use TEA recognize that hypotension may be a
result of relative hypovolemia and therapy, rather than
fluid administration, could be low-dose catecholamine
infusions or lower rates of local anesthesia infusion (to
reverse or avoid sympathectomy, respectively). It is im-
portant to point out that this recommendation is based on
physiological data, not on clinical outcomes data.
(vii) How should fluids be managed postoperatively?
Traditionally patients undergoing abdominal surgery
were not allowed oral intake postoperatively, waiting for
the gastrointestinal tract to “recover” before nutrition
could be initiated safely (including both volume (fluids)
and calories (through fluids or solid food)). In such fast-
ing patients, replacement fluids must be provided intra-
venously. With ERPs a change in philosophy has
occurred with surgeons often allowing oral intake imme-
diately after surgery—provided there is no active nausea/
vomiting. Given unrestricted access to oral fluids,
patients can regulate their intake to preserve intravascular
volume (as long as their thirst mechanisms are intact).
Isolating the impact of this paradigm shift toward early
postoperative oral intake is a challenge primarily because
of the heterogeneity among various published colorectal
ERPs. For instance, in a recent meta-analysis examining
the characteristics of 13 colorectal ERPs, 9 of 13 centers
allowed MBP, and only 8 of 13 centers protocolized peri-
operative fluid administration (Zhuang et al. 2013).
Since total fluid balance (or weight gain) after abdom-
inal surgery is directly related to both length of stay and
the incidence of complications (Brandstrup et al. 2003),
it is important to avoid both postoperative hypovolemia
and hypoperfusion (Bellamy 2006), as well as arbitrary
infusion of intravenous fluids. The use of arterial (or ple-
thysmographic) respiratory variation as guides to “fluid
responsiveness” is challenging as patients are not mech-
anically ventilated after surgery and do not typically have
invasive blood pressure monitoring in place (making ma-
neuvers such as passive leg raising inapplicable). Several
institutions, including Mayo Clinic, Duke University,
and the University of Virginia have eliminated use of
postoperative “maintenance” fluid therapy (continuous
intravenous fluid administration) in colorectal patients
who are able to tolerate the oral intake of clear liquids.
All these sites have reported significant reductions in
length of stay (Thiele et al. 2015a; Lovely et al. 2012;
Miller et al. 2014). It hence seems reasonable to avoid
intravenous fluid therapy when patients are tolerating
clear oral liquids (often immediately after surgery).
What should be done when oral fluids are not being
freely taken? In 2003, Brandstrup et al. (2003) showed
that fluid balance and daily body weight are closely cor-
related for the first four postoperative days (Tolstrup &
Brandstrup 2015) and that in patients undergoing major
abdominal surgery, there is a clear relationship between
total fluid balance and daily body weight gain and inci-
dent complications.
A meta-analysis has shown that maintaining patients
near zero-fluid balance in the perioperative period leads
to a decrease in postoperative complications with a re-
duction in length of hospital stay (Varadhan and Lobo
2010). We suggest that the fluid management framework
utilized intraoperatively should be extended into the
postoperative period, to the extent possible. In some
instances, this may not be possible due to specific
types of devices used during surgery. We suggest that
patients tolerating clear liquids orally after surgery be
given unrestricted access to such fluids and that
intravenous fluid administration be avoided in this
setting.
Future research questions
1) What are the hemodynamic effects of preoperative
isotonic bowel preparation (in the setting of an
ERP)?
2) Is there a clinical outcome difference between
simple versus complex carbohydrate loading?
3) Is a protocolized “restrictive” or “zero balance”
technique equivalent to GDFT? This may be
answered to some extent by the ongoing RELIEF
trial (https://clinicaltrials.gov/ct2/show/
NCT01424150), the focus of which is liberal
versus restrictive fluid administration but which
plans to examine the effect of GDFT using a
statistical test of interaction. However, this study
does not specifically focus on GDFT in the context
of ERPs.
4) What risk stratification tool(s) best predict outcomes
in patients undergoing colorectal surgery and what
are the clinical and financial implications of using
risk stratification to influence monitoring decisions
and hemodynamic management in patients
undergoing colorectal surgery?
5) Do colloids offer any benefits over crystalloid
for intraoperative GDFT in non-septic patients
undergoing colorectal surgery?
6) Are potential benefits of chloride-restrictive
electrolyte solutions (demonstrated in retrospective
analyses) demonstrable in prospective studies and
are there differences within available choices of
such solutions (e.g., Ringer’s lactate or Hartmann’s
solution versus PlasmaLyte)?
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Summary
Iso-osmolar bowel preparation is unlikely to lead to pre-
operative hypovolemia requiring intravenous fluid ther-
apy provided patients are given unrestricted access to
clear fluids orally. In patients that present to the operat-
ing room in a hypovolemic state, rapid detection is feas-
ible by dynamic indicators of fluid responsiveness such
as arterial (or plethysmographic) respiratory variation.
Inclusion of carbohydrates in preoperative oral fluids is
likely to improve insulin sensitivity (particular when
complex carbohydrates are used) and may reduce pro-
tein catabolism. Anuria is abnormal and requires imme-
diate attention. In general, oliguria is common during
and after anesthesia and surgery and should trigger diag-
nostic efforts but not fluid therapy until hypovolemia is
established as the cause. Intraoperative fluid therapy
should be based on a framework where all available
information is integrated to determine if there is a
physiologic problem requiring reversal. Low tidal
volumes and PEEP alter the sensitivity and specificity of
dynamic indicators of fluid responsiveness but have a
minimal impact on cardiac index at levels commonly
utilized in the operating room. To the extent possible,
the approach to intraoperative fluid management should
continue postoperatively.
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